Pelthos Therapeutics Statistics
NYSE: PTHSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
6.38-0.61 (-8.73%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Pelthos Therapeutics by the numbers
Pelthos Therapeutics has a market capitalization of $25.1 million based on 3.93M shares outstanding. With trailing EPS of $-23.86, Pelthos Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 61.4% below its 50-day average and 72.3% below its 200-day average.
Average daily trading volume is 54.38K shares, or about $346,932 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PTHS valuation vs. peer median
| Metric | PTHS | Peer median | Difference |
|---|---|---|---|
| Market cap | $25.08M | $25.03M | +0% |
| Avg. volume | 54.38K | 124.11K | -56% |
Peer median across 8 companies: INMB, SAEN, LONA, EXOZ, MGX, CVM, EVAX, KLRS.
Valuation
- Market cap
- $25.08M
- Price / sales (latest FY)
- 1.49
- EPS (TTM)
- $-23.86
- Shares outstanding
- 3.93M
Price and trading
- Previous close
- 6.99
- Open
- 6.96
- Day range
- 6.38 – 7.21
- 52-week range
- 6.02 – 31.62
- 52-week change
- -74.88%
- Beta
- —
- Volume
- 63.96K
- Average volume
- 54.38K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 25.08M
- Forward Pe
- -0.70
- Eps
- -23.86
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 31.62
- Week52 Low
- 6.02
- Avg Volume
- 54,378.00
- Shares Outstanding
- 3.93M
- Ma50
- 16.52
- Ma200
- 23.02
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -79.82%
- Pct From52w Low
- 5.98%